EFFECTS OF ALL-TRANS RETINOIC ACID AND RETINOIDS ON ANGIOGENESIS
EFFECTS OF ALL-TRANS RETINOIC ACID AND RETINOIDS ON ANGIOGENESIS
批准号:
18591015
负责人:
SUGAWARA Akira
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
天然类维甲酸全反式维甲酸(ATRA)通过维甲酸受体(RAR)调节多种重要的细胞功能。ATRA已被用于治疗各种恶性肿瘤,包括急性早幼粒细胞白血病。最近,ATRA也被认为对动脉粥样硬化性血管疾病有益。然而,它对血管生成的影响仍然存在争议。因此,我们利用人脐静脉内皮细胞(HUVEC)/正常人真皮成纤维细胞(NHDF)共培养,研究了ATRA对体外血管生成的影响,即毛细血管样管的形成。ATRA和RAR激动剂Am80显著诱导毛细血管样管形成。与RAR拮抗剂LE540/LE135共孵育可抑制atra诱导的小管形成。ATRA诱导HUVEC增殖,但不诱导其迁移。与血管内皮生长因子(VEGF)中和抗体或与VEGF受体(VEGFR)-2 (KDR)中和抗体共孵育可完全消除atra诱导的管形成,但与VEGFR-1 (Flt-1)中和抗体共孵育不能完全消除。ATRA和Am80诱导的NHDF中VEGF基因启动子受到ATRA的刺激,RAR过表达增强了VEGF基因启动子的表达。ATRA还能诱导HUVEC中VDGFR-2/KDR mRNA的表达。此外,ATRA在共培养中诱导肝细胞生长因子(HGF)和血管生成素-2 (Ang-2)的分泌。综上所述,ATRA可能主要通过刺激HUVEC增殖和增强内源性VEGF信号,部分通过诱导HGF和Ang-2的产生,通过RAR诱导血管生成。因此,类维生素a可能是治疗血管生成对抗缺血性血管疾病的潜在候选者。
英文摘要
A natural retinoid all-trans retinoic acid (ATRA) regulates a variety of important cellular functions via retinoic acid receptor (RAR). ATRA has therapeutically been utilized against various malignancies including acute promyelocytic leukemia. Recently, ATRA has also been recognized to be beneficial against atherosclerotic vascular disorders. However, its effects on angiogenesis remain controversial. We therefore examined ATRA effects on in vitro angiogenesis in terms of capillary-like tube formation using human umbilical vein endothelial cells (HUVEC)/normal human dermal fibroblasts (NHDF) co-culture. ATRA as well as RAR agonist Am80 significantly induced capillary-like tube formation. The ATRA-induced tube formation was inhibited by co-incubation with RAR antagonist LE540/LE135. HUVEC proliferation, but not its migration, was also induced by ATRA. The ATRA-induced tube formation was completely abolished by co-incubation with vascular endothelial growth factor (VEGF) neutralizing antibody or with VEGF receptor (VEGFR)-2 (KDR) neutralizing antibody, but not with VEGFR-1 (Flt-1) neutralizing antibody. ATRA and Am80 induced VEGF gene promoter in NHDF was stimulated by ATRA, which was augmented by RAR overexpression. ATRA also induced VDGFR-2/KDR mRNA expression in HUVEC. Moreover, ATRA induced secretion of hepatocyte growth factor (HGF) as well as angiopoietin-2 (Ang-2) in the co-culture. Taken together, ATRA may have induced angiogenesis via RAR mainly by stimulation of HUVEC proliferation and enhancement of endogenous VEGF signaling, and in part by induction of HGF and Ang-2 production. Retinoids may therefore be potential candiadates for therapeutic angiogenesis against ischemic vascular disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Peroxisome proliferator-activated receptor γ(PPARγ) in human breast carcinoma a modulator of estrogenic actions.
人乳腺癌中的过氧化物酶体增殖物激活受体 γ (PPARγ) 是雌激素作用的调节剂。
DOI:
--
发表时间:
2006
期刊:
Endocr Relat Cancer (In press)
影响因子:
--
作者:
[Suzuki T, Hayashi S, Miki Y, et al.]
通讯作者:
et al.
Peroxisome proliferator-activated receptor γ (PPAR γ) in human breast carcinoma: a possible modulator of estrogenic actions.
人乳腺癌中的过氧化物酶体增殖物激活受体 γ (PPAR γ):雌激素作用的可能调节剂。
DOI:
--
发表时间:
2006
期刊:
Endocr Relat Cancer 13
影响因子:
--
作者:
[Suzuki T, Hayashi S, Miki Y, Ono K, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H]
通讯作者:
Sasano H
糖尿病を有しない低機能性副腎皮質腺腫患者におけるインスリン分泌能・抵抗性の動態。
非糖尿病低功能肾上腺皮质腺瘤患者胰岛素分泌能力和抵抗力的动态变化。
DOI:
--
发表时间:
2006
期刊:
ACTH related peptides 17
影响因子:
--
作者:
[菅原 明, 伊藤貞嘉]
通讯作者:
伊藤貞嘉
Effects of ATRA and synthetic retinoid Am80 on endothelial gene expression-DNA microarray analyses
ATRA 和合成类视黄醇 Am80 对内皮基因表达的影响 - DNA 微阵列分析
DOI:
--
发表时间:
2006
期刊:
Ketsuatsu 13
影响因子:
--
作者:
[Sugawara A, Saito A, Uruno A, Imaizumi M, Kudo M, Kagechika H, Hongo M, Ito S.]
通讯作者:
Ito S.
3rd report of patients with Cushing''s syndrome who Admitted Tohoku Univ. Hosp.
东北大学就读的库欣综合征患者的第3次报告
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Sugawara A, Ito S]
通讯作者:
Ito S
共 128 条
Innovation of a novel anti-hypertensive therapy due to the inhibitionof aldosterone synthase (CYP11B2) gene expression
-
批准号:22591006
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:SUGAWARA Akira
-
依托单位:
Effect of co-activator proteins on peroxisome proliferator-activated receptor (PPAR-γ-mediated gene transcription in vascular smooth muscle cells
-
批准号:14571058
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:SUGAWARA Akira
-
依托单位:
Significance and molecular mechanisms of natriuretic peptide family in the protection from renal dysfunction
-
批准号:11671066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1999
-
负责人:SUGAWARA Akira
-
依托单位:
Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II
-
批准号:09671018
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:SUGAWARA Akira
-
依托单位:
Joint study for the thyroid hormone receptor phosphorylation
-
批准号:08044231
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$0.64万
-
财政年份:1996
-
负责人:SUGAWARA Akira
-
依托单位:
海外基金